Proteome Systems Hooks Up with Eukarion, Buck Institute to Study Proteomics of Aging

Dec 10, 2001

Premium

In support of its claim to have a hand in both proteomics technology development and discovery, Proteome Systems has signed a research partnership with Eukarion, a privately-held drug company, that will give Proteome Systems a stake in the profits from any drugs developed through the collaboration.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

PLOS Papers on Prostate Cancer by Ancestry, Korean Liver Function Genetics, Vibrio Cholerae

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

Genomics for Viral Tracking

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

Even More Personalized Medicines

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.